Dhimant Balar, DO
Sports Medicine · Freehold, NJNPI 1417001587
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,046 of the $6,750 with a category attached, or 89.6%. 20 manufacturers reported payments, led by Si-bone, Inc. at 54.6% of the total. Reporting peaked in 2022 at $2,805 and has fallen 95.0% since, to $140 in 2025.
Across 107 payments — averaging $63.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$4K
- Electronic Waveform Lab, Inc.$904
- Stryker$548
- Nevro Corp.$348
- Johnson & Johnson$270
- Amgen$208
- plus $785 from 14 others
What the payments were for
- Consulting fees$3014%
- Travel & lodging$4036%
- Food & beverage$6,04690%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 43 | $3,687 |
| Electronic Waveform Lab, Inc. | 6 | $904 |
| Stryker | 7 | $548 |
| Nevro Corp. | 4 | $348 |
| Johnson & Johnson | 12 | $270 |
| Amgen | 10 | $208 |
| Pfizer | 5 | $151 |
| Zimmer Biomet | 3 | $127 |
| Intrinsic Therapeutics | 1 | $115 |
| Boston Scientific | 1 | $77 |
| Baxter Healthcare | 1 | $69 |
| Pacira Therapeutics, Inc. | 3 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $43 |
| AbbVie | 2 | $39 |
| Bioventus LLC | 1 | $36 |
| Abbott | 1 | $25 |
| Vertex | 1 | $17 |
| Gilead | 1 | $14 |
| GSK | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iFuse Implant$1,431
- RAYOS$354
- VITOSS$146
- Omnia$119
- BARRICAID ACD (ANNULAR CLOSURE DEVICE)$115
- Senza$110
How this compares
$6,750 in reported general payments places this provider in the 80th percentile of 221 sports medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 32 | $3,049 |
| Methylprednisolone | 48 | $302 |
| Celecoxib | 12 | $215 |
| Meloxicam | 38 | $142 |
| Pregabalin | 11 | $130 |
| Cyclobenzaprine Hcl | 30 | $75 |
| Meclizine Hcl | 11 | $64 |
| Tramadol Hcl | 14 | $25 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Freehold
- Nicholas JarmonFreehold$277K
- Michael GrellerFreehold$9K
- Sean McMillanBurlington$1.8M
- Thomas YoumEnglewood$221K
- Stephen HuntCedar Knolls$76K
- David PorterHackensack$63K
- Francis AlbertaHackensack$61K
- Nathan HolmesSewell$56K
- Steven FreyWoodbury$55K
- Lon CastleFranklin Lakes$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.